Tea Tree Oil in the Treatment of Chronic Blepharitis
Launched by FEDERAL UNIVERSITY OF SÃO PAULO · Feb 19, 2010
Trial Information
Current as of May 27, 2025
Completed
Keywords
ClinConnect Summary
Patients with clinical diagnosis of chronic blepharitis were included in this study. A check list of symptoms and an ophthalmologic examination including best corrected visual acuity and biomicroscopy were performed.
Under a slit lamp visualization, three lashes with cylindrical dandruff of each eyelid were epilated by fine forceps. The lashes were immersed in fluorescein dye and examined under a light microscope at a 20-times magnification. The mites were detected based on its morphological characteristics and movement.
The patients with chronic blepharitis who had Demodex were randomly ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Chronic Blepharitis with out treatment previously
- Exclusion Criteria:
- • Patients under 18 y.o.
- • Pregnant woman
- • Others Ocular Surface Disease (Severe Dry Eye, Lagoftalmo, Entropium, Ectropium)
About Federal University Of São Paulo
The Federal University of São Paulo (Universidade Federal de São Paulo - UNIFESP) is a prestigious institution dedicated to advancing education, research, and healthcare in Brazil. Renowned for its commitment to innovation and excellence, UNIFESP plays a pivotal role in clinical research, focusing on a multidisciplinary approach to improve health outcomes. The university fosters collaboration among researchers, healthcare professionals, and community stakeholders, ensuring that clinical trials conducted under its auspices adhere to rigorous ethical standards and contribute valuable insights to the medical field. With a rich history of academic achievement and a strong emphasis on translational research, UNIFESP is a key player in the development of new therapies and medical interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sao Paulo, Sp, Brazil
Patients applied
Trial Officials
Nahin Geha
Principal Investigator
Federal University of São Paulo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials